BR112014011733A2 - suspensões autoclaváveis da forma 2 de ciclosporina a - Google Patents
suspensões autoclaváveis da forma 2 de ciclosporina aInfo
- Publication number
- BR112014011733A2 BR112014011733A2 BR112014011733A BR112014011733A BR112014011733A2 BR 112014011733 A2 BR112014011733 A2 BR 112014011733A2 BR 112014011733 A BR112014011733 A BR 112014011733A BR 112014011733 A BR112014011733 A BR 112014011733A BR 112014011733 A2 BR112014011733 A2 BR 112014011733A2
- Authority
- BR
- Brazil
- Prior art keywords
- formulations
- autoclavable
- methods
- cyclosporine
- suspensions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
Abstract
abstract disclosed herein are autoclavable formulations of cyclosporin a form 2, methods of making such formulations, and methods of treating diseases of the eye with such formulations. tradução do resumo resumo patente de invenção: "suspensões autoclaváveis da forma 2 de ciclosporina a". formulações autoclaváveis da forma 2 de ciclosporina a, métodos de produção de tais formulações, e métodos de tratamento de doenças dos olhos com tais formulações são aqui divulgados.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161559849P | 2011-11-15 | 2011-11-15 | |
PCT/US2012/064998 WO2013074616A1 (en) | 2011-11-15 | 2012-11-14 | Autoclavable suspensions of cyclosporin a form 2 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014011733A2 true BR112014011733A2 (pt) | 2017-05-09 |
Family
ID=47192237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014011733A BR112014011733A2 (pt) | 2011-11-15 | 2012-11-14 | suspensões autoclaváveis da forma 2 de ciclosporina a |
Country Status (12)
Country | Link |
---|---|
US (3) | US20130123194A1 (pt) |
EP (2) | EP2779993B1 (pt) |
JP (2) | JP6368244B2 (pt) |
KR (1) | KR102015151B1 (pt) |
CN (2) | CN104039308B (pt) |
AU (3) | AU2012339701B8 (pt) |
BR (1) | BR112014011733A2 (pt) |
CA (1) | CA2856074C (pt) |
ES (1) | ES2675269T3 (pt) |
HK (1) | HK1202078A1 (pt) |
RU (1) | RU2630970C2 (pt) |
WO (1) | WO2013074616A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013267435B2 (en) | 2012-06-01 | 2017-11-09 | Allergan, Inc. | Cyclosporin A analogs |
BR112017001017A2 (pt) | 2014-07-18 | 2018-01-23 | Allergan Inc | composições em suspensão de ciclosporina a para injeção subconjuntival e periocular |
US9914755B2 (en) | 2015-01-08 | 2018-03-13 | Allergan, Inc. | Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized |
US11452783B2 (en) * | 2017-02-14 | 2022-09-27 | Gi Supply | Tissue stain and use thereof |
CN108066745A (zh) * | 2017-12-26 | 2018-05-25 | 兆科药业(广州)有限公司 | 一种环孢素眼凝胶的处理工艺 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU203564B (en) * | 1987-12-21 | 1991-08-28 | Sandoz Ag | Process for producing new orthorombos cyclosporin without solvatation |
US5474979A (en) | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
KR980008239A (ko) * | 1996-07-26 | 1998-04-30 | 김충환 | 사이클로스포린-함유 약학적 조성물 |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
DE19819273A1 (de) * | 1998-04-30 | 1999-11-11 | Pharmatec International S Giul | Pharmazeutische Ciclosporin-Formulierung mit verbesserten biopharmazeutischen Eigenschaften, erhöhter physikalischer Qualität und Stabilität sowie Verfahren zur Herstellung |
US6254860B1 (en) | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
PT1142566E (pt) * | 2000-04-07 | 2004-02-27 | Medidom Lab | Formulacao oftalmica topica na forma de uma solucao aquosa e uso de uma ciclosporina em associacao com acido hialuronico ou um de seus sais e com polisorbato 80 |
JP2004529934A (ja) * | 2001-05-01 | 2004-09-30 | アンジオテック ファーマシューティカルズ,インコーポレイテッド | 抗微小管剤およびポリペプチドまたはポリサッカリドを含む組成物、ならびに炎症状態を処置するための医薬品の調製のためのそれらの組成物の使用 |
CN1456350A (zh) * | 2002-05-10 | 2003-11-19 | 刘继东 | 环孢素眼用凝胶 |
GB2391472B (en) | 2002-08-02 | 2004-12-08 | Satishchandra Punambhai Patel | Pharmaceutical compositions |
US20050059583A1 (en) * | 2003-09-15 | 2005-03-17 | Allergan, Inc. | Methods of providing therapeutic effects using cyclosporin components |
DE602005011928D1 (de) * | 2004-01-20 | 2009-02-05 | Allergan Inc | Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure |
WO2006003519A2 (en) * | 2004-07-02 | 2006-01-12 | Novagali Pharma Sa | Use of emulsions for intra: and periocular injection |
DE602004017477D1 (de) | 2004-11-09 | 2008-12-11 | Novagali Pharma Sa | Öl-in-Wasser-Emulsion mit niedriger Konzentration des kationischen Mittels und positivem Zetapotential |
WO2006073786A2 (en) * | 2004-12-30 | 2006-07-13 | Bausch & Lomb Incorporated | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy |
CN100431601C (zh) * | 2005-04-25 | 2008-11-12 | 北京大学 | 环孢素微球制剂治疗眼内炎症 |
US20070015691A1 (en) * | 2005-07-13 | 2007-01-18 | Allergan, Inc. | Cyclosporin compositions |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
DE102006051512A1 (de) * | 2005-12-06 | 2007-06-14 | Pari GmbH Spezialisten für effektive Inhalation | Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin |
DK1834635T3 (da) * | 2006-03-13 | 2011-10-24 | Advancell Advanced In Vitro Cell Technologies S A | Stabile nanokapselsystemer til administrtion af aktive molekyler |
US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
FR2909876A1 (fr) * | 2006-12-19 | 2008-06-20 | Galderma Res & Dev S N C Snc | Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques |
JP2011508776A (ja) * | 2008-01-04 | 2011-03-17 | アルコン ファーマシューティカルズ リミテッド | 安定な水性シクロスポリン組成物 |
WO2010006117A2 (en) * | 2008-07-10 | 2010-01-14 | Allergan, Inc. | Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
US20100303915A1 (en) * | 2009-06-02 | 2010-12-02 | Abbott Medical Optics Inc. | Therapeutic opthalmic emulsions |
WO2011049958A2 (en) * | 2009-10-21 | 2011-04-28 | Otonomy, Inc. | Modulation of gel temperature of poloxamer-containing formulations |
JP6163482B2 (ja) * | 2011-05-27 | 2017-07-12 | アラーガン、インコーポレイテッドAllergan,Incorporated | シクロスポリンaの結晶形態、その調製方法、およびその使用のための方法 |
-
2012
- 2012-11-14 ES ES12788093.8T patent/ES2675269T3/es active Active
- 2012-11-14 EP EP12788093.8A patent/EP2779993B1/en active Active
- 2012-11-14 RU RU2014123466A patent/RU2630970C2/ru active
- 2012-11-14 WO PCT/US2012/064998 patent/WO2013074616A1/en active Application Filing
- 2012-11-14 CN CN201280066530.5A patent/CN104039308B/zh active Active
- 2012-11-14 US US13/676,362 patent/US20130123194A1/en not_active Abandoned
- 2012-11-14 CN CN201810523018.8A patent/CN108714137B/zh active Active
- 2012-11-14 KR KR1020147016155A patent/KR102015151B1/ko active IP Right Grant
- 2012-11-14 AU AU2012339701A patent/AU2012339701B8/en active Active
- 2012-11-14 CA CA2856074A patent/CA2856074C/en active Active
- 2012-11-14 JP JP2014542398A patent/JP6368244B2/ja active Active
- 2012-11-14 EP EP18165454.2A patent/EP3403645A1/en not_active Withdrawn
- 2012-11-14 BR BR112014011733A patent/BR112014011733A2/pt not_active Application Discontinuation
-
2015
- 2015-03-17 HK HK15102711.7A patent/HK1202078A1/xx unknown
-
2016
- 2016-06-02 US US15/171,866 patent/US9919028B2/en active Active
-
2017
- 2017-12-12 AU AU2017276176A patent/AU2017276176A1/en not_active Abandoned
-
2018
- 2018-03-19 US US15/925,272 patent/US20180207230A1/en not_active Abandoned
- 2018-07-06 JP JP2018129131A patent/JP6829706B2/ja active Active
-
2019
- 2019-06-20 AU AU2019204332A patent/AU2019204332B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2675269T3 (es) | 2018-07-10 |
EP2779993B1 (en) | 2018-04-04 |
AU2012339701B2 (en) | 2017-10-05 |
WO2013074616A1 (en) | 2013-05-23 |
US20180207230A1 (en) | 2018-07-26 |
CN108714137B (zh) | 2022-02-01 |
AU2019204332A1 (en) | 2019-07-11 |
KR20140104960A (ko) | 2014-08-29 |
AU2017276176A1 (en) | 2018-01-18 |
AU2012339701A1 (en) | 2014-06-05 |
JP2015502351A (ja) | 2015-01-22 |
CN108714137A (zh) | 2018-10-30 |
CA2856074C (en) | 2017-07-04 |
CA2856074A1 (en) | 2013-05-23 |
CN104039308A (zh) | 2014-09-10 |
EP2779993A1 (en) | 2014-09-24 |
US20160271207A1 (en) | 2016-09-22 |
RU2630970C2 (ru) | 2017-09-15 |
US20130123194A1 (en) | 2013-05-16 |
HK1202078A1 (en) | 2015-09-18 |
JP6829706B2 (ja) | 2021-02-10 |
US9919028B2 (en) | 2018-03-20 |
CN104039308B (zh) | 2018-06-05 |
JP2018165270A (ja) | 2018-10-25 |
AU2012339701A8 (en) | 2017-11-16 |
AU2012339701B8 (en) | 2017-11-16 |
AU2019204332B2 (en) | 2020-12-24 |
RU2014123466A (ru) | 2015-12-27 |
KR102015151B1 (ko) | 2019-08-27 |
EP3403645A1 (en) | 2018-11-21 |
JP6368244B2 (ja) | 2018-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202202711B (en) | Sustained-release dosage forms of ruxolitinib | |
CY1123010T1 (el) | Διεγερση γονιδιου τrail με μικρο μοριο απο κανονικα και ογκου κυτταρα ως αντικαρκινικη θεραπεια | |
CY1118452T1 (el) | Ενωσεις και συνθεσεις ως αναστολεις πρωτεϊνικης κινασης | |
EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
EA201490004A1 (ru) | Применение bifidobacterium lactis bl-04 для лечения заболеваний дыхательных путей | |
EA201101530A1 (ru) | ИММУНОНАНОТЕРАПИЯ, ОБЕСПЕЧИВАЮЩАЯ Th1-СМЕЩЕННЫЙ ОТВЕТ | |
EA201490546A1 (ru) | Замещенные аннелированные пиримидины и их применение | |
AU2012205878A8 (en) | miRNA for treating diseases and conditions associated with neo-angiogenesis | |
WO2016037157A3 (en) | Targeting capn9/capns2 activity as a therapeutic strategy for the treatment of myofibroblast differentiation and associated pathologies | |
EA201270824A1 (ru) | Соединения для уменьшения продукции бета-амилоида | |
NZ607996A (en) | Substituted nucleotide analogs | |
EA201391719A1 (ru) | Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний | |
BR112014011770A2 (pt) | suspensões da forma 2 de ciclosporina a | |
IN2012DN02737A (pt) | ||
EA201390060A1 (ru) | Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний | |
EA201290498A1 (ru) | Терапевтические полимерные наночастицы, включающие эпотилон, и способы их получения и применения | |
EA201190217A1 (ru) | Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение | |
EA201270480A1 (ru) | Новые соединения | |
BR112014011744A2 (pt) | formulação de ação sustentável da forma 2 de ciclosporina | |
IN2012DN02645A (pt) | ||
MX2013004061A (es) | Analogos de ciclosporina. | |
EA201391154A2 (ru) | Способы и композиции для нацеливания на адипоциты у млекопитающих | |
UA107836C2 (uk) | Метод лікування хвороби альцгеймера | |
BR112014011733A2 (pt) | suspensões autoclaváveis da forma 2 de ciclosporina a | |
BR112013030554A2 (pt) | forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09S | Decision of refusal: publication cancelled [chapter 9.2.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 9.2 NA RPI NO 2700 DE 04/10/2022 POR TER SIDO INDEVIDA. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |